Panitumumab
Links shared publicly online about this topic
YouTube - Panitumumab
youtube.com — “Dr. Edith Mitchell describes a significant reduction in skin toxicity when a skin care regimen and oral antibiotic were given before panitumumab treatment fo...” View full resource at youtube.com
Most Recently Shared on June 9, 2009 at 3:55 pm By:
Bob Finn - Medical News Net Health News
Video: Dr. Edith Mitchell explains how skin care regimen + antibiotic signif. lowers panitumumab skin toxicity. http://bit.ly/YZgKE
VECTIBIX (Panitumumab) drug information from MPR
empr.com — “VECTIBIX (Panitumumab) drug information for Cancer, colorectal, Neoplasms from MPR including side effects, drug interactions, dosing, contraindications and precautions.” View full resource at empr.com
Most Recently Shared on April 29, 2010 at 4:14 am By:
MPR News: VECTIBIX: Precautions: added information on KRAS mutations, increased toxicity with combination chemotherapy. http://bit.ly/cLd2O8
Panitumumab Plus Platinum Chemo Misses Mark in Advanced Head and Neck Cancer | Oral Cancer News
oralcancernews.org — “Panitumumab Plus Platinum Chemo Misses Mark in Advanced Head and Neck Cancer | Oral Cancer News” View full resource at oralcancernews.org
Most Recently Shared on October 27, 2010 at 5:31 pm By:
The Oral Cancer Foundation Health Organization
RT @Oralcancerfnd Panitumumab Plus Platinum Chemo Misses Mark in Advanced Head and Neck Cancer http://bit.ly/cfgXBY
Panitumumab Plus Platinum Chemo Misses Mark in Advanced Head and Neck Cancer : Internal Medicine News
internalmedicinenews.com — “Panitumumab Plus Platinum Chemo Misses Mark in Advanced Head and Neck Cancer : Internal Medicine News” View full resource at internalmedicinenews.com
Most Recently Shared on October 26, 2010 at 9:33 pm By:
Bob Finn - Medical News Net Health News
#Panitumumab Plus Platinum Chemo Misses Mark in Advanced Head & Neck #Cancer. By @pwendl for Internal Medicine News http://bit.ly/bAi45B
Panitumumab/FOLFIRI improved PFS in wild-type KRAS metastatic colorectal cancer | HemOncToday
hemonctoday.com — “2010 Gastrointestinal Cancers Symposium </P” View full resource at hemonctoday.com
Most Recently Shared on January 25, 2010 at 6:28 pm By:
HemOnc Today Oncology and Health News
#ASCO GI Panitumumab/FOLFIRI improved PFS in wild-type KRAS metastatic colorectal cancer http://ow.ly/10ghn
Analysis Of Vectibix(R) Study Using New Gene Technology Helps To Advance Prospects For Personalized Medicine
medicalnewstoday.com — “Amgen (Nasdaq: AMGN) announced detailed results from a new biomarker analysis of the pivotal Phase 3 408 trial of Vectibix® (panitumumab) plus best supportive care (BSC) compared to BSC alon” View full resource at medicalnewstoday.com
Most Recently Shared on April 22, 2010 at 3:08 pm By:
Analysis Of Vectibix(R) Study Using New Gene Technology Helps To Advance Prospects For Personalized Medicine http://mnt.to/3BBz #genetics
Vectibix(R) In Combination With Chemotherapy Significantly Improves Progression-Free Survival In Second-Line Metastatic Colorectal Cancer
medicalnewstoday.com — “Amgen (Nasdaq: AMGN) announced detailed results from the Phase 3 '181' trial evaluating Vectibix((R)) (panitumumab) in combination with FOLFIRI (an irinotecan based chemotherapy), as a second-lin” View full resource at medicalnewstoday.com
Most Recently Shared on September 23, 2009 at 12:17 pm By:
MNT Clinical Trials Health News
Vectibix(R) In Combination With Chemotherapy Significantly Improves Progression-Free Survival In Second-Line Met.. http://bit.ly/1OcVFd
Vectibix(R) In Combination With Chemotherapy Significantly Improves Progression-Free Survival In First-Line Metastatic Colorectal Cancer
medicalnewstoday.com — “Amgen (Nasdaq: AMGN) announced detailed results from the Phase 3 '203' trial evaluating Vectibix(R) (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as the” View full resource at medicalnewstoday.com
Most Recently Shared on September 25, 2009 at 12:54 pm By:
MNT Clinical Trials Health News
Vectibix(R) In Combination With Chemotherapy Significantly Improves Progression-Free Survival In First-Line Met.. http://bit.ly/12AhEO
Amgen Announces Top-Line Results Of Phase 3 Head And Neck Cancer Trial
medicalnewstoday.com — “Amgen (Nasdaq: AMGN) announced top-line results from a randomized Phase 3 trial evaluating Vectibix® (panitumumab) as a first-line treatment in patients with recurrent and/or metastatic squam” View full resource at medicalnewstoday.com
Most Recently Shared on August 12, 2010 at 2:00 pm By:
MNT Ear, Nose Throat Health News
Amgen Announces Top-Line Results Of Phase 3 Head And Neck Cancer Trial http://mnt.to/3HhG #entnews
Oncology Article | Rectal Neoplasms
mdlinx.com — “Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients” View full resource at mdlinx.com
Most Recently Shared on March 16, 2011 at 5:31 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperativ... http://bit.ly/gfslHx #oncology
Gastroenterology Article | Colorectal Neoplasms
mdlinx.com — “Effective Panitumumab Treatment in Patients with Heavily Pre-treated Metastatic Colorectal Cancer: A Case Series” View full resource at mdlinx.com
Most Recently Shared on April 20, 2011 at 9:08 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Effective Panitumumab Treatment in Patients with Heavily Pre-treated Metastatic Colorectal Cancer: A Case Se... http://bit.ly/gZz5vn #GI
Oncology Article | Colorectal Neoplasms
mdlinx.com — “A Q-TWiST analysis comparing panitumumab plus best supportive care (BSC) with BSC alone in patients with wild-type KRAS metastatic colorectal cancer” View full resource at mdlinx.com
Most Recently Shared on June 2, 2011 at 8:13 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A Q-TWiST analysis comparing panitumumab plus best supportive care (BSC) with BSC alone in patients wi... http://bit.ly/mNm9z1 #oncology
Gastroenterology News & Articles - MDLinx
mdlinx.com — “Gastroenterology News & Articles - MDLinx” View full resource at mdlinx.com
Most Recently Shared on July 14, 2010 at 12:00 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Spotlight on Panitumumab in Metastatic Colorectal Cancer+: BioDrugs http://bit.ly/cN9dpN #GI
Gastroenterology News & Articles - MDLinx - Colorectal Neoplasms on #MDlinx
mdlinx.com — “Gastroenterology News & Articles - MDLinx - Colorectal Neoplasms on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on September 27, 2010 at 7:11 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer: Core Evidence http://bit.ly/9HxyDH #GI
Gastroenterology News & Articles - MDLinx - Epirubicin on #MDlinx
mdlinx.com — “Gastroenterology News & Articles - MDLinx - Epirubicin on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on August 6, 2010 at 10:59 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for advanced esophagogastric cancer: Dose... http://bit.ly/aQasm0 #GI
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Bob Finn - Medical News Net
Bringing you the latest news from scientific meetings and the policy world. Check us out at www.internalmedicinenews.com
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
The Oral Cancer Foundation
Information- Support- Advocacy- Research- Hope The foundation is an IRS registered non-profit 501(c) 3, public service charity designed for advocacy and service, created to promote change, through proactive means, in both the public and medical/dental professional sectors. At the forefront of our agenda is the firm establishment in the minds of the American public for the need to undergo an annual oral cancer screening, combined with an outreach to the dental and medical communities to provide this service as a matter of routine practice. Oral cancer takes more lives than cancers we routinely hear about, such as cervical, Hodgkin's lymphoma, skin (malignant melanoma), testicular, and many others. In the efforts to reduce the death rate from cancers in the US, the most significant progress has been made through early detection. Cervical, skin, prostate, and others that lend themselves to simple, opportunistic screenings and exams have all had their death rates reduced through programs promoting early discovery. Early discovery and diagnosis, yields better long-term outcomes, and lower morbidity to those who undergo treatments. Oral cancer is not hidden within the body in some hard to find location requiring an invasive examination, the majority of the time it is literally in plain view, right under your nose, and can be seen with the naked eye or felt with the fingers. In most cases, its early, highly survivable stages are easily detected in a 3 to 5 minute painless visual and tactile examination. Even the precancerous lesions, which can progress into malignancy, can be seen with the naked eye. An annual oral examination conducted by members of the dental and medical communities will have a definite impact on reducing the death rate associated with oral cancer. It is our mission to bring this about.
Advertisement
